Summary of Key Information:
Target Companies: Apiqo Organics Private Limited and Bizotic Lifescience Private Limited
Stock Exchange Listings:
NSE Scrip Code: AHCL
BSE Scrip Code: 544497
Nature of Transaction / Event: Shareholding acquisition via share swap
Date of Transaction: The transaction was approved at the Annual General Meeting held on 05/09/2026.
Consideration: The issue price for the preferential allotment of shares has been determined as ₹17.85 (Rupees Seventeen and Eighty Five Paise Only) per equity share.
Pricing Details:
The floor price was determined in accordance with Regulation 164 of the SEBI ICDR Regulations:
- 90-day VWAP on NSE: ₹17.85 per share
- 10-day VWAP on NSE: ₹14.99 per share
NSE was considered the recognized stock exchange due to higher trading volumes.
An independent valuation report dated September 1, 2026, from CA Gaurang Agarwal (B-10, Kamla Nagar, Agra, Uttar Pradesh – 282005) confirmed the fair value at ₹17.85 per share.
Ultimate Beneficial Owners:
The disclosure identifies 26 ultimate beneficial owners who will receive shares in the preferential allotment, including HUFs, LLPs, private limited companies, and partnership firms. The list includes entities such as Jignesh C Parekh (HUF), Xplore Knowledge Resources LLP, Mars Forge Private Limited, and Vedant Engitech And Infrastructure Private Limited, among others, along with their controlling individuals and PAN numbers.
Regulatory Context:
This disclosure is made under Regulation 30 of the SEBI LODR Regulations and is a continuation of the company's communication dated August 13, 2026, and a corrigendum dated August 25, 2026. It responds to further observations received from BSE on September 10, 2026, and NSE on September 11, 2026.
Certification:
A certificate from M/s. K.P. Ghelani & Associates, Company Secretaries, Rajkot, certifies that the preferential issue complies with Chapter V of the SEBI ICDR Regulations.
Availability of Documents:
The revised valuation report and company secretary certificate are available on the company's website at https://www.anlon.in/reports.php?subid=260&name=Preferential-Issue-Documents under the 'Investors' tab.